Evidence map›Paper›PMID 36203393›Full record

ArticleMedical physics2023

Automated lung tumor delineation on positron emission tomography/computed tomography via a hybrid regional network.

Yang Lei, Tonghe Wang, Jiwoong J Jeong, James Janopaul-Naylor, Aparna H Kesarwala, Justin Roper, Sibo Tian, Jeffrey D Bradley, Tian Liu, Kristin Higgins and 1 more

Abstract read
In one paragraph

Article in Medical physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. In Regard to Trotter et al.Advances in radiation oncology · 2024
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yang LeiDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Tonghe WangDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Jiwoong J JeongDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
James Janopaul-NaylorDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Aparna H KesarwalaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Justin RoperDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Sibo TianDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Jeffrey D BradleyDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Tian LiuDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Kristin HigginsDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.
Xiaofeng YangDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Funding

eXtended Modular ANthropomorphic (XMAN) phantom for Imaging and Treatment Optimization in Radiotherapy.R01EB032680 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE · PI REN, LEI, YANG, XIAOFENG · 2022 to 2025
$2.4M
Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor BoostR01CA215718 · NCI · EMORY UNIVERSITY · PI YANG, XIAOFENG · 2018 to 2022
$1.8M
Artificial Intelligence Driven Platform for PET/MR ImagingR56EB033332 · NIBIB · EMORY UNIVERSITY · PI MAO, HUI, YANG, XIAOFENG · 2022 to 2022
$764k
NCI NIH HHS R01 CA215718NIBIB NIH HHS R01 EB032680NIBIB NIH HHS R56 EB033332NIH HHS R01CA215718NIH HHS R56EB033332
6 · The paper itself

Abstract

backgroundMultimodality positron emission tomography/computed tomography (PET/CT) imaging combines the anatomical information of CT with the functional information of PET. In the diagnosis and treatment of many cancers, such as non-small cell lung cancer (NSCLC), PET/CT imaging allows more accurate delineation of tumor or involved lymph nodes for radiation planning. PURPOSE: In this paper, we propose a hybrid regional network method of automatically segmenting lung tumors from PET/CT images.

methodsThe hybrid regional network architecture synthesizes the functional and anatomical information from the two image modalities, whereas the mask regional convolutional neural network (R-CNN) and scoring fine-tune the regional location and quality of the output segmentation. This model consists of five major subnetworks, that is, a dual feature representation network (DFRN), a regional proposal network (RPN), a specific tumor-wise R-CNN, a mask-Net, and a score head. Given a PET/CT image as inputs, the DFRN extracts feature maps from the PET and CT images. Then, the RPN and R-CNN work together to localize lung tumors and reduce the image size and feature map size by removing irrelevant regions. The mask-Net is used to segment tumor within a volume-of-interest (VOI) with a score head evaluating the segmentation performed by the mask-Net. Finally, the segmented tumor within the VOI was mapped back to the volumetric coordinate system based on the location information derived via the RPN and R-CNN. We trained, validated, and tested the proposed neural network using 100 PET/CT images of patients with NSCLC. A fivefold cross-validation study was performed. The segmentation was evaluated with two indicators: (1) multiple metrics, including the Dice similarity coefficient, Jacard, 95th percentile Hausdorff distance, mean surface distance (MSD), residual mean square distance, and center-of-mass distance; (2) Bland-Altman analysis and volumetric Pearson correlation analysis.

resultsIn fivefold cross-validation, this method achieved Dice and MSD of 0.84 ± 0.15 and 1.38 ± 2.2 mm, respectively. A new PET/CT can be segmented in 1 s by this model. External validation on The Cancer Imaging Archive dataset (63 PET/CT images) indicates that the proposed model has superior performance compared to other methods.

conclusionThe proposed method shows great promise to automatically delineate NSCLC tumors on PET/CT images, thereby allowing for a more streamlined clinical workflow that is faster and reduces physician effort.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansImage Processing, Computer-AssistedMultimodal ImagingNeural Networks, ComputerPositron Emission Tomography Computed Tomographydeep learninglung tumorPET/CTradiotherapysegmentation

Identifiers

PMID36203393
PMCPMC9868056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.